A psychiatric 12-year follow-up of adult patients with neurofibromatosis type 1

Journal of Psychiatric Research

Volumn 33, Issue 1, 1999, Pages 63-68

  Zöller, Madeleine E T ^a,b   Rembeck, Birgitta ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Sahlgrenska U ^*  (Sweden)

Author keywords

Dysthymia; Neurofibromatosis type 1; Personality; Psychiatry; Self evaluation

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DYSTHYMIA; FEMALE; FOLLOW UP; HUMAN; MALE; MENTAL DISEASE; NEUROFIBROMATOSIS; PERSONALITY; PRIORITY JOURNAL; RATING SCALE; SELF EVALUATION; SWEDEN;

EID: 0344096547     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(98)00052-1     Document Type: Article

References (20)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC, 1987.
2. Åsberg M, Perris C, Schalling D, Sedvall G. The CPRS: development and application of a psychiatric rating scale. Acta Psychiatr Scand 1978;271 (Suppl.):1-69.
3. Bradley JW. Distribution-free statistical tests. London: Prentice-Hall, 1968.
4. Cummings JL, Benson DF. Dementia: a clinical approach. Boston: Butterworths, 1991.
5. Fitts WH. Manual. Tennessee Self Concept Scale. Nashville (TN): Counselor Recording and Tests, 1965.
6. Gutmann DH, Aysworth A, Carey JC, Korf B, Marks J, Pyeritz RE, Rubenstein A, Visckochil D. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997;278:51-57.
7. Läkemedelsverket. Farmakoterapi vid depression. Information från Läkemedelsverket. Läkemedelsverket 1995;6:309-382.
8. Mouridsen SE, Sörensen SA. Psychological aspects of von Recklinghausen neurofibromatosis (NF1). J Med Genet 1995;32:921-924.
9. National Institutes of Health Consensus Development Conference. Neurofibromatosis. Conference Statement. Arch Neurol 1988;45:575-578.
10. North K, Joy P, Yuille D, Cocks N, Mobbs E, Hutchins P, McHugh K, deSilva M. Specific learning disability in children with neurofibromatosis type 1. Neurology 1994;44:878-883.
11. North K, Joy P, Yuille P, Cocks N, Hutchins P. Cognitive function and academic performance in children with neurofibromatosis type 1. Devel Med Child Neurol 1995;37:427-436.
12. North K, Riccardi V, Samango-Sprouse C, Ferner R, Moore B, Legius E, Ratner N, Dencla MB. Cognitive function and academic performance in neuorofibromatosis 1: consensus statement. Neurology 1997;48:1121-1127.
13. Oden A, Wedel H. Arguments for Fishers permutation test. Ann Stat 1975;3:518-520
14. Samuelsson B. Neurofibromatosis (von Recklinghausens disease). A clinical psychiatric, and genetic study. University of Göteborg, 1981.
15. Samuelsson B, Samuelsson S. Neurofibromatosis in Gothenburg, Sweden. I. Background, study design and epidmiology. Neurofibromatosis 1989;2:84-106
16. Samuelsson B, Samuelsson S, Palmertz B. Cranial computed tomography in patients with neurofibromatosis and neurological impairment. In: Berg JM, editor. Science and service in mental retardation. Baltimore: University Park Press, 1985. p. 102-8.
17. Schalling D, Edman G. The Karolinska Scales of Personality (KSP). An inventory for assessing temperament dimensions associated with vulnerability for psychosocial deviance. Manual. Stockholm: The Department of Psychiatry, The Karolinska Institute, 1993.
18. Zöller ME, Rembeck B, Åkesson HO, Angervall L. Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Göteborg, Sweden. Acta Derm Venerol 1995;75:136-140.
19. Zöller MET, Rembeck B, Angervall L. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population. Cancer 1997;79:2125-2131.
20. Zöller MET, Rembeck B, Bäckman L. Neuropsychological deficits in adults with neurofibromatosis type 1. Acta Neurol Scand 1997;95:225-232.